BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3781652)

  • 1. Mineral metabolism during a hemofiltration session in children.
    Bianchi ML; Bettinelli A; Soldati L; Saccaggi A; Ortolani S; Edefonti A
    Int J Artif Organs; 1986 Jul; 9(4):257-62. PubMed ID: 3781652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone, calcium and phosphate balance in hemofiltration.
    Fuchs C; Doht B; Dorn D; McIntosh C; Ritter D; Scheler F
    J Dial; 1977; 1(6):631-40. PubMed ID: 608872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of hemofiltration on plasma levels of parathyroid hormone and calcitonin].
    De Fremont JF; Fournier A; Gueris J; Caillens C; Coevoet B; Lambrey G; Quichaud J
    J Urol Nephrol (Paris); 1978; 84(4-5):323-8. PubMed ID: 682233
    [No Abstract]   [Full Text] [Related]  

  • 5. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin in chronic renal failure.
    Garancini S; Ballada L; Roncari G; Gastaldi L
    Nephron; 1983; 34(4):224-7. PubMed ID: 6877457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofiltration and calcium-phosphate metabolism.
    Bianchi ML; Soldati L; Giaretto S; Valenti G; Cresseri D; Lorenz M; Buccianti G
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():51-4. PubMed ID: 3557673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
    Koskimies O; Ala-Houhala M
    Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and parathyroid disorders in children. Chronic renal failure and treatment with calcitriol.
    Chan JC; DeLuca HR
    JAMA; 1979 Mar; 241(12):1242-4. PubMed ID: 762789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Kinetic of calcium, phosphate, magnesium and PTH variations during hemodiafiltration].
    Rius A; Hernández-Jaras J; Pons R; García Pérez H; Torregrosa E; Sánchez Canel JJ; Fenollosa MA; Pin MT; Tamarit E; Calvo C
    Nefrologia; 2007; 27(5):593-8. PubMed ID: 18045035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone and osteocalcin levels in plasma and ultrafiltrate during hemofiltration.
    Weiss LG; Danielson BG; Jüppner H; Ljunghall S; Wide L
    Scand J Urol Nephrol; 1993; 27(1):109-14. PubMed ID: 8493457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis.
    McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F
    Nephron; 1977; 19(2):88-94. PubMed ID: 887190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
    Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
    Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute suppression of parathyroid activity during hemofiltration.
    Panichi V; Bianchi AM; Andreini B; Casarosa L; Migliori M; De Pietro S; Ferdeghini M; Palla R
    Blood Purif; 1996; 14(1):15-9. PubMed ID: 8718560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcium and phosphate metabolism in hemofiltration (author's transl)].
    Fuchs C; Dorn D; Henning HV; Matthaei D; McIntosh C; Kramer P; Ritter D; Schünemann B; Scheler F
    Klin Wochenschr; 1978 Dec; 56(23):1163-9. PubMed ID: 713437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density in children with chronic renal failure.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Jan; 22(1):121-7. PubMed ID: 16977474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.